CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
CorMedix Therapeutics (Nasdaq: CRMD) announced that senior management will participate in a fireside chat and investor meetings at the Wells Fargo 21st Annual Healthcare Conference in Boston, held on September 8–10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CorMedix Therapeutics (Nasdaq: CRMD) announced that senior management will participate in a fireside chat and investor meetings at the Wells Fargo 21st Annual Healthcare Conference in Boston, held on September 8–10, 2026. The fireside chat webcast is scheduled for Wednesday, September 9, 2026, at 12:45 p.m. EDT, with a replay available on the company’s investor relations website.
Details
News Market Reaction – CRMD
On Sep 1, the day this news came out, CRMD closed 1.27% above the previous close.
Data tracked by StockTitan Argus for the Sep 1 session.
Key Figures
- Conference Edition
- 21st Annual
- Wells Fargo Healthcare Conference
- Conference Dates
- September 8–10, 2026
- Upcoming Wells Fargo Healthcare Conference
- Fireside Chat
- September 9, 2026
- Scheduled conference presentation
- Webcast Time
- 12:45pm EDT
- September 9, 2026 fireside chat
Historical Context
-
Revenue growth, raised EBITDA guidance, and expanded dialysis-provider coverage
-
Scheduled Q2 financial results and corporate update conference call
-
Federal Circuit affirmed patent validity and permanent generic-product injunction
-
Participation in RBC Capital Markets and Jefferies healthcare conferences
-
Raised 2026 revenue and EBITDA guidance alongside positive Phase III results
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be participating in a fireside chat and investor meetings at the upcoming Wells Fargo 21st Annual Healthcare Conference being held in Boston on September 8 – 10, 2026.
| Wells Fargo 21st Annual Healthcare Conference | |
| Date: Time: Webcast: | Wednesday, September 9, 2026 12:45pm EDT Click here |
A replay of the fireside chat will also be available in the “Presentations and Events” page on the investor relations portion of the Company’s website at: www.cormedix.com
About CorMedix
CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. For more information visit: www.cormedix.com.
Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.